Related Experiment Videos
Summary
This review summarizes traditional organ-specific enzyme assays for cancer evaluation. It also discusses serum enzymes and tissue analysis for monitoring disease progression and exploring new enzyme-based cancer diagnostics.
Area of Science:
- Oncology
- Biochemistry
- Clinical Diagnostics
Background:
- Traditional enzyme assays are crucial in evaluating patients with cancer.
- Serum enzymes like gamma-glutamyl transpeptidase, phosphohexose isomerase, and 5'-nucleotidase aid in monitoring disease course, especially with liver metastasis.
- Enzyme analysis in biopsy tissue, biological fluids, and body cavity washings offers diagnostic utility.
Purpose of the Study:
- To summarize established organ-specific enzyme assays for cancer patient evaluation.
- To outline the role of specific serum enzymes in monitoring cancer progression, particularly liver metastases.
- To explore the potential of novel enzymes as future diagnostic tools and for understanding cancer etiology.
Main Methods:
- Review of existing literature on organ-specific enzyme assays in oncology.
- Analysis of the application of serum enzymes (e.g., GGT, PHI, 5'-NT) in disease monitoring.
- Consideration of enzyme analysis in various biological samples (tissue, fluids, washings).
Main Results:
- Established organ-specific enzyme assays are foundational in cancer diagnosis.
- Certain serum enzymes are valuable for tracking disease activity, especially in cases of liver metastasis.
- Enzyme profiling in diverse biological samples provides critical diagnostic information.
Conclusions:
- Enzyme assays, both traditional and serum-based, are indispensable in cancer management.
- Analysis of enzyme activity in various bodily samples aids in diagnosis and monitoring.
- Future research into novel enzymes holds promise for enhanced cancer detection and etiological studies.